WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

FDA begins push to study psychedelics for mental health disorders - UPI.com

The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.

Raccontata datheguardian.comcnbc.comupi.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
upi.comStai leggendo2 mesi fa

FDA begins push to study psychedelics for mental health disorders - UPI.com

The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.

originale
cnbc.com2 mesi fa

FDA fast-tracks psychedelic drug research following Trump executive order

It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.

Leggi questa versione → originale
theguardian.com2 mesi fa

Trump psychedelics order largely symbolic, analysts say

Executive order to speed access to psychedelic treatments likely to have limited legal impact despite high-profile push

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 24 aprile 2026·theguardian.com

    Trump psychedelics order largely symbolic, analysts say

    Executive order to speed access to psychedelic treatments likely to have limited legal impact despite high-profile push

  2. venerdì 24 aprile 2026·cnbc.com

    FDA fast-tracks psychedelic drug research following Trump executive order

    It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.

  3. venerdì 24 aprile 2026·upi.com

    FDA begins push to study psychedelics for mental health disorders - UPI.com

    The FDA announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs.